NIM Norwood Imm.

 

TIDMNIM 
 
RNS Number : 5811P 
Norwood Immunology Ld 
27 March 2009 
 
NORWOOD IMMUNOLOGY LIMITED 
 
 
Temporary suspension of trading in securities 
 
 
Norwood Immunology Limited and its subsidiaries ("Norwood Immunology" or the 
"Group") (AIM:NIM), the Group focused on stem cell therapies, the rejuvenation 
and repair of the immune system and the development of virosomal vaccines, today 
announces that its AIM securities will today be suspended pursuant to the AIM 
Rules for Companies as Norwood Immunology will be unable to publish its interim 
report for the six months ended 31 December 2008 by 31 March 2009. This has been 
as a consequence of the proposed disposal of Bestewil Holdings B.V. and 
finalisation of the Group's Annual Report and Accounts for the year ended 30 
June 2008 announced on 6 and 10 March 2009 respectively. 
 
 
A further announcement will be made in due course. 
 
 
For further information please contact: 
 
 
+-----------------------------------------------+------------------------+ 
| Norwood Immunology Limited                    |                        | 
+-----------------------------------------------+------------------------+ 
| Richard Williams, Chief Executive Officer     | +44 (0)7860 295153     | 
+-----------------------------------------------+------------------------+ 
|                                               |                        | 
+-----------------------------------------------+------------------------+ 
| KBC Peel Hunt Ltd (NOMAD Adviser and Broker)  | +44 (0)207 418 8900    | 
+-----------------------------------------------+------------------------+ 
| Capel Irwin                                   |                        | 
+-----------------------------------------------+------------------------+ 
| David Anderson                                |                        | 
+-----------------------------------------------+------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 SUSPUUBAWUPBGRQ 
 

Grafico Azioni Norwood Immunology (LSE:NIM)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Norwood Immunology (LSE:NIM)
Storico
Da Giu 2023 a Giu 2024